Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
2.5-10
General Information
Revision date
2014-04-17
Product name
20-3025HY-25 HYSQ PUMPKIN
1.2.1 Relevant identified uses
Electrostatic coating for use in industrial plants
Emergency telephone
800-424-9300, 703-527-3887
Icons in SDS
Company Information
company name
Saffire Blue, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
saffireblue@saffireblue.ca
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Emergency overview Physical state : Solid. [Powder.] Odor : Odorless.
Signal word
WARNING!
Hazard statements
CAUSES EYE AND SKIN IRRITATION. MAY CAUSE RESPIRATORY TRACT IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. POSSIBLE CANCER HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE CANCER, BASED ON ANIMAL DATA.
Precautionary statements
Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe dust. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation : Slightly irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion : No known significant effects or critical hazards. Skin : Irritating to skin. Eyes : Irritating to eyes. Potential chronic health effects
Potential chronic health
Contains material that may cause target organ damage, based on animal data. Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Carcinogenicity : Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: lungs, cardiovascular system, upper respiratory tract, skin, eyes. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions aggravated by over- exposure : Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. See toxicological information (Section 11)
